BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37329383)

  • 1. Amelioration of Cognitive and Olfactory System Deficits in APOE4 Transgenic Mice with DHA Treatment.
    González LM; Bourissai A; Lessard-Beaudoin M; Lebel R; Tremblay L; Lepage M; Graham RK
    Mol Neurobiol; 2023 Oct; 60(10):5624-5641. PubMed ID: 37329383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice.
    Lessard-Beaudoin M; M Gonzalez L; AlOtaibi M; Chouinard-Watkins R; Plourde M; Calon F; Graham RK
    Eur J Neurosci; 2021 Nov; 54(9):7092-7108. PubMed ID: 34549475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2.
    Vandal M; Alata W; Tremblay C; Rioux-Perreault C; Salem N; Calon F; Plourde M
    J Neurochem; 2014 May; 129(3):516-26. PubMed ID: 24345162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating the plasma-liver-brain axis of omega-3 fatty acid metabolism in mouse knock-in for the human apolipoprotein E epsilon 4 allele.
    Husain MA; Vachon A; Chouinard-Watkins R; Vandal M; Calon F; Plourde M
    J Nutr Biochem; 2023 Jan; 111():109181. PubMed ID: 36220526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isoform-specific pathological effects of apoE4 in vivo are prevented by a fish oil (DHA) diet and are modified by cholesterol.
    Kariv-Inbal Z; Yacobson S; Berkecz R; Peter M; Janaky T; Lütjohann D; Broersen LM; Hartmann T; Michaelson DM
    J Alzheimers Dis; 2012; 28(3):667-83. PubMed ID: 22057027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of DHA on cognitive dysfunction in aging and Alzheimer's disease: The mediating roles of ApoE.
    Zhang X; Yuan T; Chen X; Liu X; Hu J; Liu Z
    Prog Lipid Res; 2024 Jan; 93():101256. PubMed ID: 37890592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Diet Rich in Docosahexaenoic Acid Restores Liver Arachidonic Acid and Docosahexaenoic Acid Concentrations in Mice Homozygous for the Human Apolipoprotein E ε4 Allele.
    Chouinard-Watkins R; Pinçon A; Coulombe JD; Spencer R; Massenavette L; Plourde M
    J Nutr; 2016 Jul; 146(7):1315-21. PubMed ID: 27306896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review.
    Yassine HN; Braskie MN; Mack WJ; Castor KJ; Fonteh AN; Schneider LS; Harrington MG; Chui HC
    JAMA Neurol; 2017 Mar; 74(3):339-347. PubMed ID: 28114437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DHA-Enriched Fish Oil Ameliorates Deficits in Cognition Associated with Menopause and the
    Pontifex MG; Martinsen A; Saleh RNM; Harden G; Fox C; Muller M; Vauzour D; Minihane AM
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E4 causes early olfactory network abnormalities and short-term olfactory memory impairments.
    Peng KY; Mathews PM; Levy E; Wilson DA
    Neuroscience; 2017 Feb; 343():364-371. PubMed ID: 28003161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHA Selectively Protects SAMP-8-Associated Cognitive Deficits Through Inhibition of JNK.
    Vela S; Sainz N; Moreno-Aliaga MJ; Solas M; Ramirez MJ
    Mol Neurobiol; 2019 Mar; 56(3):1618-1627. PubMed ID: 29911253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice.
    Engstrom AK; Snyder JM; Maeda N; Xia Z
    Mol Neurodegener; 2017 Feb; 12(1):14. PubMed ID: 28173832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DHA brain uptake and APOE4 status: a PET study with [1-
    Yassine HN; Croteau E; Rawat V; Hibbeln JR; Rapoport SI; Cunnane SC; Umhau JC
    Alzheimers Res Ther; 2017 Mar; 9(1):23. PubMed ID: 28335828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial.
    Arellanes IC; Choe N; Solomon V; He X; Kavin B; Martinez AE; Kono N; Buennagel DP; Hazra N; Kim G; D'Orazio LM; McCleary C; Sagare A; Zlokovic BV; Hodis HN; Mack WJ; Chui HC; Harrington MG; Braskie MN; Schneider LS; Yassine HN
    EBioMedicine; 2020 Sep; 59():102883. PubMed ID: 32690472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of phosphatidylcholine-DHA in preventing APOE4-associated Alzheimer's disease.
    Patrick RP
    FASEB J; 2019 Feb; 33(2):1554-1564. PubMed ID: 30289748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid prevents cognitive deficits in human apolipoprotein E epsilon 4-targeted replacement mice.
    Chouinard-Watkins R; Vandal M; Léveillé P; Pinçon A; Calon F; Plourde M
    Neurobiol Aging; 2017 Sep; 57():28-35. PubMed ID: 28595105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    Stanitsa E; Economou A; Beratis I; Kontaxopoulou D; Fragkiadaki S; Papastefanopoulou V; Pavlou D; Papantoniou P; Kroupis C; Papatriantafyllou J; Stefanis L; Yannis G; Papageorgiou SG
    J Alzheimers Dis; 2021; 84(3):1005-1014. PubMed ID: 34602476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Influence of
    Martinsen A; Saleh RNM; Chouinard-Watkins R; Bazinet R; Harden G; Dick J; Tejera N; Pontifex MG; Vauzour D; Minihane AM
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-195 rescues ApoE4-induced cognitive deficits and lysosomal defects in Alzheimer's disease pathogenesis.
    Cao J; Huang M; Guo L; Zhu L; Hou J; Zhang L; Pero A; Ng S; El Gaamouch F; Elder G; Sano M; Goate A; Tcw J; Haroutunian V; Zhang B; Cai D
    Mol Psychiatry; 2021 Sep; 26(9):4687-4701. PubMed ID: 32632205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.